In renal clear cell carcinoma, the combined analysis of BRD9 and other chromatin-regulated genes showed a significant association with the high-risk groups and lower overall survival, providing a prediction model for further research investigating the role of the expression of BRD genes in cancers [70]. This evidence concerns the gene BRD9 and cancer.